Data / Form D filings / Galera Therapeutics LLC
Galera Therapeutics LLC: Form D filings
Galera Therapeutics LLC, a pharmaceuticals company in St. Louis, MO, filed 4 Form D notices with the SEC between 2010 and 2011. The latest, on September 27, 2011, reports $405,000 sold of a $405,000 offering to 1 investor.
Find out what Galera Therapeutics LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4041 FOREST PARK AVENUE, St. Louis, MO, 63108
- Phone
- (314) 615-6324
- Industry
- Pharmaceuticals
- Entity type
- Limited Liability Company
- Incorporated in
- Missouri
- Year incorporated
- 2009
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1492474
The full lists. Form D filings in Missouri: 379 rows, $18.95, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 27, 2011 | Amendment | $405,000 | $405,000 | $0 | 1 | Mar 21, 2011 | sec.gov |
| Apr 5, 2011 | New notice | $205,000 | $205,000 | $0 | 1 | Mar 21, 2011 | sec.gov |
| Jan 31, 2011 | Amendment | $805,000 | $805,000 | $0 | 8 | May 11, 2010 | sec.gov |
| May 25, 2010 | New notice | $680,000 | $680,000 | $0 | 3 | May 11, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Catherine L. Matthes | Executive Officer | |
| Robert L. Calcaterra | Director | |
| Eric L. Gulve | Director | |
| Robert A. Beardsley | Executive Officer, Director | |
| Jeffery L. Keene | Executive Officer | |
| Dennis L. Riley | Executive Officer | |
| Phillip L. Buckler | Executive Officer |
Other pharmaceuticals companies in Missouri that filed recently
- Immunophotonics, Inc. $10.1 million · Sep 4, 2026
Every Form D from the week of Sep 26, 2011 · All recent filings in Missouri · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Galera Therapeutics LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.